Preventive effect of taurine on experimental type II diabetic nephropathy. - Wikidata - awgldk - TriplyDB

Preventive effect of taurine on experimental type II diabetic nephropathy.

Preventive effect of taurine on experimental type II diabetic nephropathy.

http://www.wikidata.org/entity/Q34364305

about

Effects of taurine and housing density on renal function in laying hens Taurine alleviates the progression of diabetic nephropathy in type 2 diabetic rat model.The role of taurine in renal disorders.Dendrobium Officinale Kimura et Migo Ameliorates Insulin Resistance in Rats with Diabetic Nephropathy.

P2860

Q37518280-DC3C18D2-0C93-49CC-8741-FBFB8695DE95 Q37636034-C8EA420A-4C7B-4E42-8165-9CDD77D9DB91 Q38009667-AC01B313-EE8E-4C30-A848-073E67EF865B Q55170613-4FAAB46E-F2FB-496F-99F3-FB5F7F47A0E8

P2860

Preventive effect of taurine on experimental type II diabetic nephropathy.

http://www.wikidata.org/entity/Q34364305

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Preventive effect of taurine on experimental type II diabetic nephropathy.

@ast

Preventive effect of taurine on experimental type II diabetic nephropathy.

@en

Preventive effect of taurine on experimental type II diabetic nephropathy.

@nl

type

label

Preventive effect of taurine on experimental type II diabetic nephropathy.

@ast

Preventive effect of taurine on experimental type II diabetic nephropathy.

@en

Preventive effect of taurine on experimental type II diabetic nephropathy.

@nl

prefLabel

Preventive effect of taurine on experimental type II diabetic nephropathy.

@ast

Preventive effect of taurine on experimental type II diabetic nephropathy.

@en

Preventive effect of taurine on experimental type II diabetic nephropathy.

@nl

P1433

Q34364305-22C59C4D-9500-4BD3-BE39-73241869B87D

P1476

Q34364305-944A1F02-54D0-43CA-BA7D-2DD0C90273A4

P2093

Q34364305-25E77F55-317A-4A1F-A2F8-84C96651F25B

Q34364305-4786793B-F3CF-4B36-889C-7F31A79A5618

Q34364305-47F1BDB8-3565-4290-8B11-FE7C5EE84B09

Q34364305-484086E9-62FB-4937-833E-329A9F29B4F1

Q34364305-55116787-6157-4177-B89D-F688C03338A3

Q34364305-669D732E-D532-4176-9C7A-A11B1E3A9F18

Q34364305-ABA54B29-AD23-42AA-969B-C838B344C983

Q34364305-E746B6A5-33E9-4EA0-90B6-627BF57183C2

P2860

Q34364305-14C4122F-C088-4D42-ABE6-B856CDA58A44

Q34364305-1740A541-ACEA-47B3-801F-5A0C036DC504

Q34364305-1B8B8542-9F6F-41B7-B4A1-47387F2F15F7

Q34364305-3A66E4AD-715C-41A0-8392-CE9368DEC7CA

Q34364305-5D0F9D8D-653B-4CA3-A8A2-19965EAE098B

Q34364305-6F5069D2-025B-408E-ADAE-F38F29E3D8C6

Q34364305-876CC2EC-BD2D-4772-97E4-DC6891A8D852

Q34364305-95C55B8C-D82E-4DF4-A9B0-149D7741B163

Q34364305-A00F096E-0EF2-4B7D-9430-69DA3284D61A

Q34364305-A1F0B82E-544D-4AD6-BFAD-AA3283734F59

P2888

Q34364305-3C474253-E403-4CFA-9F30-75268A8990F5

P304

Q34364305-3AE08140-08CA-44A1-ADC5-A07054C5EF3E

P31

Q34364305-C0CBD108-0F2F-44F1-B7BE-EC437CD88D42

P356

Q34364305-28097036-CC48-4DDE-A442-14463021A82A

P478

Q34364305-0CF85B9A-9B8A-4F68-9C32-AE43A61CFB19

P577

Q34364305-DA16E5C9-792C-4A0F-B74B-7F4BA3436DC0

P698

Q34364305-A3C290DD-A718-41D7-9EE9-A0ACF48CF902

P932

Q34364305-F62AF327-CB34-43F8-9576-469001ED6220

P356

1423-0127-17-S1-S46

P1433

Journal of Biomedical Science

P1476

Preventive effect of taurine on experimental type II diabetic nephropathy.

@en

P2093

Gaofeng Wu

http://www.w3.org/2001/XMLSchema#string

He Zhao

http://www.w3.org/2001/XMLSchema#string

Jiancheng Yang

http://www.w3.org/2001/XMLSchema#string

Jianmin Hu

http://www.w3.org/2001/XMLSchema#string

Mei Liu

http://www.w3.org/2001/XMLSchema#string

Qiufeng Lv

http://www.w3.org/2001/XMLSchema#string

Shumei Lin

http://www.w3.org/2001/XMLSchema#string

Xinhong Luan

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Evidence for coiled-coil alpha-helical regions in the long arm of laminin.

Laminin--a glycoprotein from basement membranes.

Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.

The laminin B2 chain has a multidomain structure homologous to the B1 chain.

Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix.

The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury.

Protective actions of taurine against streptozotocin-induced hyperglycemia.

P2888

1423-0127-17-s1-s46

P304

S46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1423-0127-17-S1-S46

http://www.w3.org/2001/XMLSchema#string

P478

17 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20804623

http://www.w3.org/2001/XMLSchema#string

P932

2994380

http://www.w3.org/2001/XMLSchema#string